SCHEMBL8090221

SCHEMBL8090221

O=C(O)c1cn2c3c(c(F)c(F)cc3c1=O)OCC21CCC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 3/20 0.47
KDM4E B2RXH2 7/20 0.44
KMT2A Q03164 1/20 0.44
TOP1 P11387 2/20 0.44
ALDH1A1 P00352 3/20 0.41
POLB P06746 2/20 0.41
HSP90AA1 P07900 1/20 0.41
RXFP1 Q9HBX9 1/20 0.41
TOP2A P11388 4/20 0.39
TOP2B Q02880 4/20 0.39
HPGD P15428 2/20 0.39
HSD17B10 Q99714 2/20 0.39
ALB P02768 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
AADAT Q8N5Z0 2/20 0.39
TUBB4A P04350 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39
TUBA4A P68366 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1185901 0.98 GSK3B (0.47) GSK3BKDM4EKMT2ATOP1ALDH1A1
SCHEMBL1185781 0.95 KDM4E (0.45) GSK3BKDM4EKMT2ATOP1ALDH1A1
SCHEMBL1185913 0.85 STAT3 (0.47) GSK3BKDM4EKMT2AALDH1A1HPGD
SCHEMBL2191820 0.84 GSK3B (0.46) GSK3BKDM4EKMT2ATOP1ALDH1A1
SCHEMBL1185837 0.83 STAT3 (0.47) GSK3BKDM4EKMT2AALDH1A1HPGD
SCHEMBL9872072 0.82 KDM4E (0.63) GSK3BKDM4EKMT2ATOP1ALDH1A1
SCHEMBL1186154 0.80 STAT3 (0.48) KDM4EKMT2AALDH1A1HPGDHSD17B10
SCHEMBL15090760 0.80 KDM4E (0.46) KDM4EKMT2ATOP1ALDH1A1POLB
SCHEMBL12873913 0.79 GSK3B (0.63) GSK3BPOLBTOP2ATOP2B
SCHEMBL1185725 0.77 GSK3B (0.63) GSK3BPOLBTOP2ATOP2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2009035684-A1 SPIROCYCLIC AMINOQUINOLONES AS GSK-3 INHIBITORS ACTIVX BIOSCIENCES, INC. (US) 2009-03-19 WO disclosed